Filing Details

Accession Number:
0001628280-19-010643
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-08-12 18:37:45
Reporting Period:
2019-08-08
Accepted Time:
2019-08-12 18:37:45
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1397702 Silk Road Medical Inc SILK Surgical & Medical Instruments & Apparatus (3841) 208777622
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1414561 Warburg Pincus X, L.p. C/O Warburg Pincus Llc
450 Lexington Avenue
New York NY 10017
No No Yes No
1414564 L.p. Gp X Pincus Warburg C/O Warburg Pincus Llc
450 Lexington Avenue
New York NY 10017
No No Yes No
1414565 Warburg Pincus Private Equity X, L.p. C/O Warburg Pincus Llc
450 Lexington Avenue
New York NY 10017
No No Yes No
1451560 Warburg Pincus X Partners, L.p. C/O Warburg Pincus Llc
450 Lexington Avenue
New York NY 10017
No No Yes No
1621224 Warburg Pincus Partners Gp Llc C/O Warburg Pincus Llc
450 Lexington Avenue
New York NY 10017
No No Yes No
1621242 Warburg Pincus Partners, L.p. C/O Warburg Pincus Llc
450 Lexington Avenue
New York NY 10017
No No Yes No
1621874 Wpp Gp Llc C/O Warburg Pincus Llc
450 Lexington Avenue
New York NY 10017
No No Yes No
1770767 Wp X Finance, L.p. C/O Warburg Pincus Llc
450 Lexington Avenue
New York NY 10017
No No Yes No
1770772 Wpx Gp, L.p. C/O Warburg Pincus Llc
450 Lexington Avenue
New York NY 10017
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2019-08-08 4,163,328 $39.50 8,036,301 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. In connection with the Issuer's follow-on public offering, 4,034,265 shares were sold by WP X Finance, L.P. ("WP X Finance"), and 129,063 shares were sold by Warburg Pincus X Partners, L.P. ("WPXP"), each to the underwriters of the follow-on public offering.
  2. Pursuant to an underwritten public offering of the Issuer's common stock (the "Offering"), on August 8, 2019, the Issuer, WP X Finance, WPXP, other selling stockholders, and the underwriters of the Offering (the "Underwriter"), entered into an Underwriting Agreement (the "Underwriting Agreement"). Pursuant to the Underwriting Agreement, WP X Finance and WPXP sold an aggregate of 4,163,328 shares of common stock of the issuer to the Underwriters. The per share sale price reported in this Form 4 does not reflect underwriting discounts.
  3. 7,787,181 of these shares are held by "WP X Finance" and 249,120 of these shares are held by Warburg Pincus X Partners, L.P. ("WPXP").
  4. WPX GP, L.P., a Delaware limited partnership ("WPX GP"), is the managing general partner of WP X Finance. Warburg Pincus Private Equity X, L.P., a Delaware limited partnership ("WP X"), is the general partner of WPX GP. Warburg Pincus X, L.P., a Delaware limited partnership ("WPX LP"), is the general partner of WPX and WPXP. Warburg Pincus X GP L.P., a Delaware limited partnership ("WP X GP LP"), is the general partner of WPX LP. WPP GP LLC, a Delaware limited liability company ("WPP GP"), is the general partner of WP X GP LP. Warburg Pincus Partners, L.P., a Delaware limited partnership ("WP Partners"), is the managing member of WPP GP. Warburg Pincus Partners GP LLC, a Delaware limited liability company ("WP Partners GP"), is the general partner of WP Partners.
  5. (continuation from footnote 3) Warburg Pincus & Co., a New York general partnership ("WP"), is the managing member of WP Partners GP. Charles R. Kaye and Joseph P. Landy are each Managing General Partners of WP and may each be deemed to control the Warburg Pincus entities. Messrs. Kaye and Landy disclaim beneficial ownership of all shares held by the Warburg Pincus entities.